- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04985981
The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study
November 26, 2021 updated by: Michel Adamina, MD
The Prediction of Anastomotic Insufficiency Risk After Colorectal Surgery (PANIC) Study: Development and External Validation of an International, Multicenter Machine Learning Algorithm for Prediction of Anastomotic Insufficiency After Colonic or Colorectal Anastomosis
The Prediction of Anastomotic Insufficiency risk after Colorectal surgery (PANIC) study aims to establish a machine-learning-based application that allows for accurate preoperative prediction of patients at risk for anastomotic insufficiency after colon and colorectal surgery.
Study Overview
Status
Suspended
Detailed Description
Anastomotic insufficiency leads to clinical strains for patients, and significantly increases morbidity and mortality.
On average, hospital stay is extended by 12 days while healthcare-related expenses are increased by 30,000 USD when patients suffer from an anastomotic leak.
In experienced centers, the approximated incidence of anastomotic insufficiency is 3,3% for colon and 8.6% for colorectal procedures.
Multiple subgroups of patients with increased risk for anastomotic leaks have been described in previous publications.
Meticulous preoperative recognition of patients with increased risk for anastomotic insufficiency is clinically beneficial, as it would permit improved ressource preparation, enhanced patient education and superior surgical decision-making.
However, it is often difficult for clinicians to balance the plethora of crucial risk factors for anastomotic leaks for a single patient.
Machine learning methods have been exceptionally effective at incorporating various clinical variables into one unified risk prediction model.
To the authors' best knowledge, there does not yet exist a credible prediction model or a conclusive prediction score for anastomotic insufficiency after colon and colorectal anastomosis.
The aim of the Prediction of Anastomotic Insufficiency risk after Colorectal surgery (PANIC) study is to establish and externally validate an efficient machine-learning-based prediction tool based on multicenter data from a range of international centers.
Study Type
Observational
Enrollment (Anticipated)
11000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Basel
-
Allschwil, Basel, Switzerland, 4123
- Clinical Research and Artificial Intelligence in Surgery, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
-
-
Zürich
-
Winterthur, Zürich, Switzerland, 8401
- Kantonsspital Winterthur
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who underwent colon or colorectal anastomosis for neoplasia, diverticulitis, mesenterial ischemia, iatrogenic or traumatic perforation, or inflammatory bowel disease.
Only patients who have reached the age of 18 will be accepted.
Only patients who are able to give informed consent to the procedure will be accepted.
Description
Inclusion Criteria:
- Patients who underwent colon or colorectal anastomosis for neoplasia, diverticulitis, mesenterial ischemia, iatrogenic or traumatic perforation, or inflammatory bowel disease
Exclusion Criteria:
- age < 18
- recurrent colorectal cancer
- peritoneal carcinomatosis or unresectable metastatic disease at time of bowel resection
- informed consent not obtainable
- follow-up < 6 weeks after surgery
- no reversal of and ostomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of Anastomotic leak
Time Frame: 5 years
|
Occurrence of anastomotic insufficiency/leak is defined as any clinical signs of leakage, confirmed by radiological examination, endoscopy, clinical examination of the anastomosis, or upon reoperation.
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occurrence of Death
Time Frame: 90 days
|
90 days
|
|
|
Time to diagnosis of anastomotic leak
Time Frame: 90 days
|
Time to diagnosis of a leakage will be calculated as days between the index operation and diagnosis of the leakage by imaging with extraluminal contrast, endoscopy, re-operation, or when fecal containing fluid is objectified in a drainage.
|
90 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disease-free survival (months)
Time Frame: 5 years
|
5 years
|
|
|
Overall survival (months)
Time Frame: 5 years
|
5 years
|
|
|
Adjuvant/additive immunochemotherapy (yes/no)
Time Frame: 5 years
|
Did the patient receive adjuvant/additive immunochemotherapy after surgery?
(yes/no)
|
5 years
|
|
Adjuvant/additive radiotherapy (yes/no)
Time Frame: 5 years
|
Did the patient receive adjuvant/additive radiotherapy after surgery?
(yes/no)
|
5 years
|
|
Additive curative surgery (no/yes: liver; lung; locoragional relapse)
Time Frame: 5 years
|
Did the patient receive additive curative surgery after the initial intervention?
(no/yes: liver; lung; locoragional relapse)
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Michel Adamina, Prof. Dr. med., Clinical Research and Artificial Intelligence in Surgery, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland
- Principal Investigator: Anas Taha, Dr. med., None currently
- Principal Investigator: Thomas Steffen, Cantonal Hospital of St. Gallen
- Principal Investigator: Stephanie Taha-Mehlitz, Dr. med., Department of Visceral Surgery, Clarunis, University Hospital Basel, Basel, Switzerland
- Principal Investigator: Frédéric Ris, Prof. Dr. med., Department of Surgery, Hôpitaux Universitaires de Genève
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2021
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
December 31, 2022
Study Registration Dates
First Submitted
July 22, 2021
First Submitted That Met QC Criteria
July 22, 2021
First Posted (Actual)
August 2, 2021
Study Record Updates
Last Update Posted (Actual)
December 1, 2021
Last Update Submitted That Met QC Criteria
November 26, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Peritoneal Diseases
- Postoperative Complications
- Gastrointestinal Diseases
- Gastroenteritis
- Intestinal Diseases
- Pathological Conditions, Anatomical
- Inflammatory Bowel Diseases
- Ischemia
- Crohn Disease
- Anastomotic Leak
- Diverticulum
- Diverticular Diseases
- Mesenteric Ischemia
Other Study ID Numbers
- PANIC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.